Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Oncotarget|July 25, 2018
TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin ASin Ying Cheung, Matthias Henrot, Mohammad Al-Saad, et al.The Journal of Biological Chemistry|March 23, 2017
Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channelsHussein N Rubaiy, Melanie J Ludlow, Matthias Henrot, et al.Nature|December 17, 2020
Small-molecule inhibitors of human mitochondrial DNA transcriptionNina A Bonekamp, Bradley Peter, Hauke S Hillen, et al.Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.Cell Chemical Biology|February 4, 2018
Dynarrestin, a Novel Inhibitor of Cytoplasmic DyneinSusanne Höing, Ting-Yu Yeh, Matthias Baumann, et al.Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.Stem Cell Reports|February 19, 2019
Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In VivoLydia Reinhardt, Susanne Kordes, Peter Reinhardt, et al.The EMBO Journal|October 7, 2024
TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemiaJenny Bröker-Lai, José Rego Terol, Christin Richter, et al.Pageof 5